Bristol-Myers Squibb Company (BMY)
STRONG BUYUS listed
This page tracks Bristol-Myers Squibb Company (BMY) with live price data, technical indicators (RSI, MACD, moving averages, Sharpe ratio), and AI-powered analysis. Our scanner continuously reviews BMY against ~5,000 North American equities — fusing market fundamentals with frontier AI to surface high-conviction opportunities before they break out.
Latest AI Analysis
Updated Jun 11, 202649% confidenceThe pre-screen STRONG_BUY signal is not supported by the current technical and fundamental picture. While BMY shows a bullish MACD crossover and trades above its 50-day SMA, it is burdened by recent negative catalyst (Takeda's zasocitinib beat Sotyktu head-to-head), weak momentum (Sharpe 0.45, RSI neutral at 51), and macroeconomic headwinds (fear sentiment, low inflation data). The stock has declined from $60.59 to $57.26 over the period, and volume today is below average, suggesting weak conviction. Confirmation of the STRONG_BUY is not warranted.
Get the full picture for BMY — free.
Add BMY to a watchlist for instant scanner alerts. Run an on-demand 30-day AI price forecast. See the full historical signal track record. Free tier, no credit card.
Get scanner alerts and AI forecasts for BMY
Free tier includes daily AI recommendations, charts with indicators, and a 3-stock watchlist. No credit card.
Get Started →